Skip to main content

Table 4 The 5-year overall survival rate of patients with both genes co-expression

From: The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance

Groups Gene expression Cases Survival 5-year OS (%) Compared Rank test
a Beclin-1++/PCNA++ 2 0 0   
b Beclin-1++/PCNA+ 20 13 65.0 b vs. c P=0.008
c Beclin-1+/PCNA++ 18 3 16.7 b vs. d P=0.025
d Beclin-1+/PCNA+ 63 19 30.2 C vs. d P>0.05
e Beclin-1++/NET-1++ 5 2 40.0 E vs. f P>0.05
f Beclin-1++/NET-1+ 17 11 64.7 f vs g P=0.000
g Beclin-1+/NET-1++ 32 4 12.5 h vs g P=0.003
h Beclin-1+/NET-1+ 49 18 36.7 f vs h P=0.046
i Beclin-1++/Bcl-2++ 1 0 0   
j Beclin-1++/Bcl-2+ 21 13 61.9 J vs k P=0.000
k Beclin-1+/Bcl-2++ 10 1 10.0 J vs l P=0.029
l Beclin-1+/Bcl-2+ 71 21 29.6 l vs k P=0.015
m Beclin-1++/Bax++ 5 5 100.0   
n Beclin-1++/Bax+ 17 8 47.1 n vs. o P>0.05
o Beclin-1+/Bax++ 10 7 70.0 n vs. p P>0.05
p Beclin-1+/Bax+ 71 15 21.1 o vs. p P=0.010
q Beclin-1++/MVD++ 1 1 100.0   
r Beclin-1++/MVD+ 21 12 57.1 r vs. s P=0.000
s Beclin-1+/ MVD++ 33 3 21.2 r vs. t P=0.043
t Beclin-1+/ MVD+ 48 15 31.3 s vs. t P>0.05
  1. +, including – and +.